Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Venture Investment & Partnering (VIP) Forums
Share |

VIP Forum with Japan Tobacco Pharmaceutical Division




Plenary Session | February 28, 2017 | OPEN TO ALL | REGISTER HERE

5:00PM Registration | 5:30-6:30PM Informational Session | 6:30PM Networking


One-on-One Meeting Opportunity | March 1, 2017 as scheduled 

Applications are now closed


The Pharmaceutical Division of Japan Tobacco Inc. (JT Pharma) is dedicated to healthcare through discovery and development of "First-in-Class" drugs which change the patient's life for the better. Executives from JT Pharma will be in Seattle February 28 and March 1 for a Plenary Session and 1:1 meetings with local companies, entrepreneurs, and research groups.


Japan Tobacco 1:1 Meeting Opportunity:

JT Pharma is seeking partnering opportunities for collaborative research at early R&D phases, as well as in-licensing opportunities of preclinical – clinical phase assets. JT Pharma is also looking to meet with companies possessing novel, cutting-edge drug R&D technologies.


Collaborative research at early phases:

Focus on identification and development of orally active small molecule therapeutics

Diseases of interest:

·         Diabetes

·         Sarcopenia

·         Chronic heart failure

·         Multiple sclerosis

·         Fibrosis

·         HIV latency

·         HBV

·         Dyslipidemia/Atherosclerosis

·         Diabetic complications

·         Non-alcoholic steatohepatitis

·         Peripheral artery disease

·         Inflammatory bowel disease

·         Systemic lupus erythematosus

·         Chronic kidney disease


In-licensing at clinical phases:

Focus on development of small molecules, proteins, antibodies, or nucleic acid as therapeutics in Japan

Diseases of interest:

·         Renal diseases

·         Allergic diseases

·         Dermatological diseases


Drug R&D technologies:

Technologies related to translational research using cell culture, isolated cellular organelles and related mechanisms; HTS technologies; protein structure analysis; chemical biology, chemical synthesis, and chemical libraries; biophysical tools; in silico technologies; biomarkers and bioinformatics.


If you have questions about this application, please contact Wendy Yang at


There are no fees for either of these events; companies and groups chosen for 1:1 meetings MUST be Life Science Washington members.


Thank you to our VIP Forum Sponsor:


If you have questions or are interested in visiting Seattle as a VIP or sponsoring VIP Forums, please contact Patricia Beckmann at


VIP Forum Application for 1:1 Meetings

Venture Investment & Partnering (VIP) Forums bring investors and strategic partners to Seattle for a showcase of the most promising life science companies and research opportunities in Washington. Companies and researchers are invited to submit an application to be considered for one-on-one meetings with venture investors and strategic partners (VIPs) from BioPharma, Medical Device, Digital Health and Health IT, and Global Health.

Why apply now?

* Apply once for all current and future VIP Forums
* All companies and researchers will be contacted for consent prior to review of your application by VIPs
* Anyone can apply; MUST be Life Science Washington members to participate in one-on-one meeting if selected

Apply at:


VIP Forum Structure
VIPs get a fully coordinated visit to Seattle, where VIPs have pre-scheduled individual meetings with Washington’s most innovative startups and researchers, curated to their interests. VIPs can also discuss their investment/partnering strategies as part of an informational session and have opportunities to meet with key industry leaders.




more Calendar

VIP Forum with Japan Tobacco Pharmaceutical Division

Life Science Bootcamp Course- WSU Spokane

Featured Partners
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership  ::  Legal